János Szlávik

759 total citations
35 papers, 328 citations indexed

About

János Szlávik is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, János Szlávik has authored 35 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 10 papers in Neurology and 7 papers in Epidemiology. Recurrent topics in János Szlávik's work include COVID-19 Clinical Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Long-Term Effects of COVID-19 (10 papers). János Szlávik is often cited by papers focused on COVID-19 Clinical Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Long-Term Effects of COVID-19 (10 papers). János Szlávik collaborates with scholars based in Hungary, France and Denmark. János Szlávik's co-authors include Eszter Újhelyi, Dénes Bánhegyi, István Vályi‐Nagy, Botond Lakatos, George Füst, Zoltán Prohászka, Steffen Thiel, Julianna Lisziewicz, Franco Lori and Enikő R. Tőke and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

János Szlávik

33 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
János Szlávik Hungary 10 164 80 70 55 43 35 328
Audrey L. Butler United States 6 165 1.0× 116 1.4× 60 0.9× 19 0.3× 35 0.8× 7 343
Jaiprasath Sachithanandham United States 10 240 1.5× 38 0.5× 93 1.3× 54 1.0× 32 0.7× 36 358
Carolyn M. Boudreau United States 7 184 1.1× 189 2.4× 154 2.2× 23 0.4× 62 1.4× 10 457
Abeer Moanna United States 11 309 1.9× 101 1.3× 208 3.0× 66 1.2× 50 1.2× 20 536
Terrance Ku Canada 10 183 1.1× 47 0.6× 88 1.3× 11 0.2× 15 0.3× 13 285
Hannah L. Itell United States 14 165 1.0× 140 1.8× 166 2.4× 59 1.1× 71 1.7× 23 432
Melisa D. Rett United States 13 265 1.6× 102 1.3× 161 2.3× 139 2.5× 30 0.7× 16 548
Katherine McMahan United States 11 502 3.1× 160 2.0× 67 1.0× 112 2.0× 128 3.0× 16 646
Priyanka Uprety United States 11 186 1.1× 46 0.6× 83 1.2× 84 1.5× 44 1.0× 19 345
Surabhi B Vora United States 10 92 0.6× 27 0.3× 158 2.3× 26 0.5× 41 1.0× 31 354

Countries citing papers authored by János Szlávik

Since Specialization
Citations

This map shows the geographic impact of János Szlávik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by János Szlávik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites János Szlávik more than expected).

Fields of papers citing papers by János Szlávik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by János Szlávik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by János Szlávik. The network helps show where János Szlávik may publish in the future.

Co-authorship network of co-authors of János Szlávik

This figure shows the co-authorship network connecting the top 25 collaborators of János Szlávik. A scholar is included among the top collaborators of János Szlávik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with János Szlávik. János Szlávik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Vályi‐Nagy, István, Zoltán Szekanecz, Krisztina Bogos, et al.. (2023). Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant. Vaccines. 11(12). 1786–1786. 2 indexed citations
4.
Karászi, Éva, János Szlávik, Vera Goda, et al.. (2023). Infekciók kockázatának csökkentése veleszületett és szerzett komplementdefektusokban.. Orvosi Hetilap. 164(25). 971–980. 1 indexed citations
5.
6.
Szabó, Bálint Gergely, Péter Reményi, László Gopcsa, et al.. (2023). Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study. Journal of Clinical Medicine. 12(15). 5000–5000.
7.
Müller, Veronika, István Vályi‐Nagy, Alexandra Nagy, et al.. (2022). Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant. Vaccines. 10(7). 986–986. 10 indexed citations
8.
Szabó, Bálint Gergely, et al.. (2022). Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary. GeroScience. 44(5). 2427–2445. 1 indexed citations
9.
Törő, Klára, János Szlávik, Botond Lakatos, et al.. (2021). A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. GeroScience. 43(5). 2265–2287. 19 indexed citations
10.
Szabó, Bálint Gergely, et al.. (2021). Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary. Journal de Mycologie Médicale. 31(4). 101198–101198. 14 indexed citations
11.
12.
Szlávik, János, Tamás Varga, K. Rácz, et al.. (2021). Acute Heart Transplantation from Mechanical Circulatory Support in a Human Immunodeficiency Virus-Positive Patient with Fulminant Myocarditis. ESC Heart Failure. 8(2). 1643–1648. 1 indexed citations
13.
Lakatos, Botond, László Gopcsa, Eszter Molnár, et al.. (2020). Citokinellenes terápia az új típusú koronavírus okozta megbetegedés (COVID–19) kezelésében – tocilizumab elsőként való alkalmazása egy hazai infektológiai osztályon (A COVID–19-pandémia orvosszakmai kérdései). Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 6 indexed citations
14.
Müller, Viktor, Anita Koroknai, Márta Marschalkó, et al.. (2019). Transmitted drug resistance in newly diagnosed and treatment-naïve HIV type 1-infected patients in Hungary. Journal of Global Antimicrobial Resistance. 20. 124–130. 8 indexed citations
15.
Sulyok, Mihály, Tamás Ferenci, Mihály Makara, et al.. (2017). Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals. PeerJ. 5. e2867–e2867. 4 indexed citations
16.
Llibre, Josep M., Alessandro Cozzi‐Lepri, Court Pedersen, et al.. (2016). Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression. Medicine. 95(40). e5020–e5020. 1 indexed citations
17.
Sulyok, Mihály, Mihály Makara, Tamás Ferenci, et al.. (2015). Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter. European Journal of Gastroenterology & Hepatology. 27(6). 679–685. 23 indexed citations
18.
Lisziewicz, Julianna, Nyasha Bakare, Sandra A. Calarota, et al.. (2012). Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals. PLoS ONE. 7(5). e35416–e35416. 51 indexed citations
19.
Takács, Mária, et al.. (2005). Genotypic distribution of human herpesvirus-8 strains circulating in HIV-positive patients with and without Kaposi’s sarcoma in Hungary. Archives of Virology. 150(7). 1315–1326. 6 indexed citations
20.
Prohászka, Zoltán, Mohamed R. Daha, Caner Süsal, et al.. (1999). C1q Autoantibodies in HIV Infection: Correlation to Elevated Levels of Autoantibodies against 60-kDa Heat-Shock Proteins. Clinical Immunology. 90(2). 247–255. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey L. Butler Breakdown of academic impact, for papers by Jaiprasath Sachithanandham Breakdown of academic impact, for papers by Carolyn M. Boudreau Breakdown of academic impact, for papers by Abeer Moanna Breakdown of academic impact, for papers by Terrance Ku Breakdown of academic impact, for papers by Hannah L. Itell Breakdown of academic impact, for papers by Melisa D. Rett Breakdown of academic impact, for papers by Katherine McMahan Breakdown of academic impact, for papers by Priyanka Uprety Breakdown of academic impact, for papers by Surabhi B Vora
Rankless by CCL
2026